Trials / Completed
CompletedNCT01800812
Effects of OM-174 in Adult Patients With Solid Tumors
Phase One Study With Direct Individual Benefit: Effects of OM-174 in Adult Patients With Solid Tumors.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 27 (planned)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Methods Patients received OM-174 twice weekly for a total of 5, 10 or 15 injections of either 600, 800 or 1000 µg/m². Pharmacokinetic analysis and cytokine dosages were performed. Natural Killer cells activity and toll-like receptors 4 polymorphism analysis were also performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Injections of OM-174 |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2008-01-01
- First posted
- 2013-02-28
- Last updated
- 2013-02-28
Source: ClinicalTrials.gov record NCT01800812. Inclusion in this directory is not an endorsement.